Salveen Richter
Stock Analyst at Goldman Sachs
(3.61)
# 751
Out of 5,182 analysts
212
Total ratings
44.44%
Success rate
7.08%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $28 → $32 | $35.20 | -9.09% | 11 | Apr 1, 2026 | |
| DNLI Denali Therapeutics | Maintains: Buy | $35 → $40 | $20.65 | +93.70% | 6 | Mar 26, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgrades: Neutral | $61 → $25 | $22.45 | +11.36% | 4 | Mar 24, 2026 | |
| GENB Generate Biomedicines | Initiates: Buy | $26 | $13.75 | +89.09% | 1 | Mar 24, 2026 | |
| QURE uniQure | Maintains: Neutral | $37 → $9 | $17.16 | -47.55% | 10 | Mar 3, 2026 | |
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $49.20 | -16.67% | 11 | Feb 17, 2026 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.44 | -23.82% | 3 | Nov 5, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $22.96 | -30.31% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $74.79 | -13.09% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $40.41 | -55.46% | 9 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $21.84 | +19.05% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $504 → $566 | $318.85 | +77.51% | 6 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $38 | $9.48 | +300.84% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $23.23 | -18.21% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $22.20 | -23.41% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $38.83 | -4.71% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $49.51 | -5.07% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $55.50 | +87.39% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $19.38 | +111.56% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $14.81 | -32.48% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $761.85 | +5.53% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $177.34 | +11.09% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $12.54 | +43.54% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $139.71 | -31.29% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $13.13 | -8.61% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $190.42 | -62.19% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $95.93 | -27.03% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $347.94 | +0.59% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $438.71 | +27.42% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $39.69 | -87.40% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.48 | +1,150.00% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $238.08 | -5.49% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.32 | +562.65% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.21 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.84 | +413.70% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.11 | +189.39% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.37 | -31.35% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.20 | +87.50% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $73.02 | -41.11% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.41 | -41.35% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $4.99 | +1,904.01% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $8.18 | +7,239.45% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $118.32 | -57.74% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $61.03 | -26.27% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Apr 1, 2026
Maintains: Neutral
Price Target: $28 → $32
Current: $35.20
Upside: -9.09%
Denali Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $20.65
Upside: +93.70%
Ultragenyx Pharmaceutical
Mar 24, 2026
Downgrades: Neutral
Price Target: $61 → $25
Current: $22.45
Upside: +11.36%
Generate Biomedicines
Mar 24, 2026
Initiates: Buy
Price Target: $26
Current: $13.75
Upside: +89.09%
uniQure
Mar 3, 2026
Maintains: Neutral
Price Target: $37 → $9
Current: $17.16
Upside: -47.55%
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $49.20
Upside: -16.67%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.44
Upside: -23.82%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $22.96
Upside: -30.31%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $74.79
Upside: -13.09%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $40.41
Upside: -55.46%
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $21.84
Upside: +19.05%
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $318.85
Upside: +77.51%
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.48
Upside: +300.84%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $23.23
Upside: -18.21%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $22.20
Upside: -23.41%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $38.83
Upside: -4.71%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $49.51
Upside: -5.07%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $55.50
Upside: +87.39%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $19.38
Upside: +111.56%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $14.81
Upside: -32.48%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $761.85
Upside: +5.53%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $177.34
Upside: +11.09%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $12.54
Upside: +43.54%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $139.71
Upside: -31.29%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $13.13
Upside: -8.61%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $190.42
Upside: -62.19%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $95.93
Upside: -27.03%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $347.94
Upside: +0.59%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $438.71
Upside: +27.42%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $39.69
Upside: -87.40%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.48
Upside: +1,150.00%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $238.08
Upside: -5.49%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.32
Upside: +562.65%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $21.21
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.84
Upside: +413.70%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.11
Upside: +189.39%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.37
Upside: -31.35%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.20
Upside: +87.50%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $73.02
Upside: -41.11%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.41
Upside: -41.35%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $4.99
Upside: +1,904.01%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $8.18
Upside: +7,239.45%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $118.32
Upside: -57.74%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $61.03
Upside: -26.27%